New eye drop trial aims to halt worsening vision in kids
NCT ID NCT06579287
Summary
This study is testing whether a new eye drop called SHJ002 can safely slow down the progression of nearsightedness in children aged 3 to 12. It will compare SHJ002 to atropine, a medication already used for this purpose. Researchers will measure changes in the children's eyeglass prescriptions and the length of their eyes to see which treatment works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA, PROGRESSIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cathay General Hospital
Taipei, 106, Taiwan
-
Chang Cung Memorial Hospital-Tucheng
New Taipei City, 236, Taiwan
-
Changhua Christian Hospital
Chang-hua, Taiwan
-
Chung Shan Medical University Hospital
Taichung, 402, Taiwan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, 813, Taiwan
-
MacKay Memorial Hospital-Tamsui
New Taipei City, 251, Taiwan
-
Pacific Center for Advanced Vision Care Tanasbourne Vision Center
Hillsboro, Ohio, 97124, United States
-
Taipei Veterans General Hospital
Taipei, 201, Taiwan
-
Tri-Service General Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.